Literature DB >> 23361850

[Overview: liver tumors].

Ivo Graziadei1.   

Abstract

Since the introduction of abdominal ultrasound liver lesions have been increasingly detected. Being usually diagnosed by chance these lesions create psychological stress among patients because a potential malignant disease has to be taken into consideration. The increasing use of oral contraceptives with high estrogen doses starting in the 1980s led to a rising incidence of adenomas, whose natural history differed from those described in surgical and autoptic studies. This fact brought about a change towards a modern pathophysiologic and prognostic differentiation. Current histologic and molecular biological techniques are able to distinguish benign adenomas from those with malignant potential.

Entities:  

Mesh:

Year:  2013        PMID: 23361850     DOI: 10.1007/s10354-013-0177-5

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  23 in total

1.  Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations.

Authors:  Morris Sherman; Jordi Bruix; Michael Porayko; Tram Tran
Journal:  Hepatology       Date:  2012-07-30       Impact factor: 17.425

Review 2.  Loco-regional treatment of hepatocellular carcinoma.

Authors:  Riccardo Lencioni
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

Review 3.  Fibrolamellar hepatocellular carcinoma.

Authors:  Shu Liu; Kwok Wah Chan; Bingyuan Wang; Liang Qiao
Journal:  Am J Gastroenterol       Date:  2009-07-28       Impact factor: 10.864

4.  Natural history of hepatic haemangiomas: clinical and ultrasound study.

Authors:  L Gandolfi; P Leo; L Solmi; E Vitelli; G Verros; A Colecchia
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

Review 5.  Resection and liver transplantation for hepatocellular carcinoma.

Authors:  Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

Review 7.  Management of benign hepatic tumors.

Authors:  Joseph F Buell; Hadrien Tranchart; Robert Cannon; Ibrahim Dagher
Journal:  Surg Clin North Am       Date:  2010-06-08       Impact factor: 2.741

8.  Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation.

Authors:  Gavin C Harewood; Todd H Baron; Linda M Stadheim; Benjamin R Kipp; Thomas J Sebo; Diva R Salomao
Journal:  Am J Gastroenterol       Date:  2004-08       Impact factor: 10.864

9.  Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Gabrielle Couchy; Brigitte Le Bail; Antonio Sa Cunha; Anne Rullier; Christophe Laurent; Jean-Frédéric Blanc; Gaelle Cubel; Hervé Trillaud; Jessica Zucman-Rossi; Charles Balabaud; Jean Saric
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

10.  MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement.

Authors:  Kyongtae T Bae; Cheng Tao; Fang Zhu; James E Bost; Arlene B Chapman; Jared J Grantham; Vicente E Torres; Lisa M Guay-Woodford; Catherine M Meyers; William M Bennett
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.